6079 Overall survival of patients with KRAS wild-type tumours treated with FOLFOX4± cetuximab as 1st-line treatment for metastatic colorectal cancer: The OPUS study

作者： C. Bokemeyer , I. Bondarenko , J.T. Hartmann , F. DeBraud , G. Schuch

DOI: 10.1016/S1359-6349(09)71174-7

关键词: Oncology 、 Cetuximab 、 Colorectal cancer 、 Overall survival 、 Internal medicine 、 Wild type 、 KRAS 、 Medicine 、 Line (text file)